Adriamycin-induced changes of creatine kinase activity in vivo and in cardiomyocyte culture

Toxicology

Volumn 134, Issue 1, 1999, Pages 51-62

  Deatley, S Michael ^a   Aksenov, Michael Y ^a,b   Aksenova, Marina V ^a   Jordan, Brad ^a   Carney, John M ^a,c   Butterfield, D Allan ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c EVOTEC AG   (Germany)

Author keywords

Adriamycin; Cardiomyocytes; Cardiotoxicity; Creatine kinase; Oxygen free radicals

Indexed keywords

CREATINE KINASE ISOENZYME; DOXORUBICIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE CELL; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELLS, CULTURED; CREATINE KINASE; DOXORUBICIN; HEART; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

EID: 0033046059     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(99)00039-6     Document Type: Article

References (52)

1. Adachi T., Nagae T., Ito Y., Hirano K., Sugiur M. Relation between cardiotoxic effects of adriamycin and superoxide anion radical. J. Pharmacobiodyn. 6:1983;114-123.
2. Arena E., Arico M., Biondo F., Dusonchet N., Gebbia L., Gerbasi R., Sanguedolce R., Rausa L Analysis of some probable factors responsible for adriamycin-induced cardiotoxicity. Second International Symposium on Adriamycin. 1974;Belgium European Press, Medikon.
3. Bachur N.R., Gordon S.L., Gee M.V. A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res. 38:1978;1745-1750.
4. Banerjee A., Grosso M.A., Brown J.M., Rogers K.B., Whitman G.J.R. Oxygen metabolite effects on creatine kinase and cardiac energetics after reperfusion. Am. J. Physiol. 261:1991;H590-H597.
5. Beauchamp C., Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal. Biochem. 44:1971;276-287.
6. Bessman S.P. The creatine-creatine phosphate energy shuttle. Ann. Rev. Biochem. 54:1985;831-862.
7. Butterfield D.A. β-amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chem. Res. Toxicol. 10:1997;495-506.
8. Butterfield D.A., Stadtman E.R. Protein oxidation processes in aging brain. Mattson M.P., Geddes J.W. Advances in Cell Aging and Gerontology. 1997;161-191 JAI Press, Greenwich, CT.
9. DeAtley S.M., Aksenov M.Y., Aksenova M.V., Carney J.M., Butterfield D.A. Adriamycin induces protein oxidation in erythrocyte membranes. Pharmacol. Toxicol. 93:1998;62-68.
10. DeAtley S.M., Aksenov M.Y., Aksenova M.V., Harris B., Hadley R., Harper P.C., Carney J.M., Butterfield D.A. Antioxidants protect against reactive oxygen species associated with adriamycin-treated cardiomyocytes. Cancer Letts. 136:1999;41-46.
11. Demant E.J., Wassermann K. Doxorubicin induced alterations in lipid metabolism of cultured myocardial cells. Biochem. Pharm. 34:1985;1741-1746.
12. Doroshow J.H., Locker G.Y. Role of oxygen radical formation in anthracycline cardiac toxicity. Muggia FM, Young C.W., Carter S.K. Anthracycline Antibiotics in Cancer Therapy. 1982;317-330 Martinus Nijhoff, Le Hague.
13. Doroshow J.H. Effect of anthracycline antibiotics on oxygen free radical formation in rat heart. Cancer Res. 43:1983;460-472.
14. Doroshow J.H., Tallent C., Schechter J.E. Ultrastructural features of adriamycin-induced skeletal and cardiac muscle toxicity. Am. J. Pathol. 118:1985;288-297.
15. Escobar J.A., Rubio M.A., Lissi E.A. SOD and catalase inactivation by singlet oxygen and peroxyl radicals. Free Rad. Biol. Med. 20:1996;285-290.
16. Floyd R.A., Henderson R., Watson J.J., Wong P.K. Use of salicylate with high pressure liquid chromatography and electrochemical detection (LCED) as a sensitive measure of hydroxyl free radical in adriamycin treated rats. J. Free Rad. Biol. Med. 2:1986;13-18.
17. 2-. Biochem. Biophys Res. Commun. 116:1983;1107-1113.
18. Goodman J., Hochstein P. Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin. Biochem. Biophys. Res. Commun. 77:1977;797-803.
19. Gutteridge J.C. Lipid peroxidation and possible hydroxyl radical formation stimulated by the self-reduction of doxorubicin-iron (III) complex. Biochem. Pharmacol. 33:1984;1725-1728.
20. Handa K., Sato S. Generation of free radical of quinone group containing anticancer chemical NADPH microsome system as evidenced by initiation of sulfite oxidation. Gann. 66:1975;43-47.
21. Hansen M.B., Nielsen S.E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Meth. 119:1989;203-210.
22. Hescheler J., Meyer R., Plant S., Krautwurst D., Rosenthal W., Schultz G. Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ. Res. 69:1991;1476-1486.
23. Jacobus W.E. Respiratory control and the integration of heart-energy phosphate metabolism by the mitochondrial creatine kinase. Annu. Rev. Physiol. 47:1985;707-725.
24. Julicher R.H., van der Laarse A., Sterrenberg L., Bloys van Treslong C.H., Bast A., Noordhoek J. The involvement of an oxidative mechanism in the adriamycin induced toxicity in neonatal rat heart cell cultures. Res. Commun. Chem. Pathol. Pharmacol. 47:1985;35-47.
25. Kalyanaraman B., Morehouse K.M., Mason R.P. An electron paramagnetic resonance study of the interactions between the adriamycin semiquinone, hydrogen peroxide, iron-chelators, and radical scavengers. Arch. Biochem. Biophys. 286:1991;164-170.
26. Kimes B.W., Brandt B.L. Properties of a clonal muscle cell line from rat heart. Exp. Cell Res. 98:1976;367-381.
27. Lefrak E.A., Pitha J., Rosenheim S., Gottlieb J.A. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer. 32:1973;302-314.
28. Mao G.D., Thomas P.D., Lopaschuk G.D., Poznansky M.J. Superoxide dismutase (SOD)-catalase conjugates: role of hydrogen peroxide and the Fenton reaction in SOD toxicity. J. Biol. Chem. 268:1993;416-420.
29. Minnaugh E.G., Trush M.A., Gram T.E. Enhancement of rat heart microsomal lipid peroxidation following doxorubicin treatment in vivo. Cancer Treat. Rep. 67:1983;731-733.
30. Monti E., Piccinini F., Villani F., Favalli L. Myocardial contractility and heart pharmacokinetic of adriamycin following a single administration in rat. Cancer Chemother. Pharmacol. 18:1986;289-291.
31. Myers C.E. The role of free radical damage in the genesis of doxorubicin cardiac toxicity. Muggia FM, Young C.W., Carter S.K. Anthracycline antibiotics in cancer chemotherapy. 1982;297-305 Martinus Nijhoff, The Hague.
32. 3+-ADP-adriamycin complex. Fed. Eur. Biochem. Soc. Lett. 166:1984;232-236.
33. Ollinger K., Brunmark A. Effect of different oxygen pressures and N,N-diphenyl-p-phenylenediamine on adriamycin toxicity to cultured neonatal rat heart myocytes. Biochem. Pharmacol. 48:1994;1707-1715.
34. Olson R.D., Boerth R.C., Gerber J.G., Nies A.S. Mechanism of adriamycin cardiotoxicity: evidence for oxidative stress. Life Sci. 29:1981;1393-1401.
35. Olson R.D., Mushlin P.S. Doxorubicin cardiotoxicity: analysis of prevailing hypothesis. J. Fed. Am Soc. Exp. Biol. 4:1990;3076-3086.
36. Pigeolet E., Corbisier P., Houbion A., Lambert D., Michiels C., Raes M., Zachary M.D., Remacle J. Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech. Ageing Dev. 51:1990;283-297.
37. Pinteaux E., Copin J.C., Ledig M., Tholey G. Modulation of oxygen-radical-scavenging enzymes by oxidative stress in primary cultures of rat astroglial cells. Dev. Neurosci. 18:1996;397-404.
38. Rajagopalan S., Politi P.M., Sinha B.K., Myers C.E. Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Cancer Res. 48:1988;4766-4769.
39. Schlege J., Zubriggen B., Wegman J., Wysis N., Eppenberger M., Wallimann T. Native mitochrondrial creatine kinase forms octameric structures. I. Isolation of two interconvertible mitochrondrial creatine kinase forms, dimeric and octameric mitochondrial creatine kinase forms, dimeric and octameric mitochrondrial creatine kinase: characterization, localization and structure-function relationships. J. Biol. Chem. 32:1988;16942-16953.
40. Steinherz L.J., Steinherz P.G., Tan C.C., Heller G., Murphy L. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. J. Am. Med. Assoc. 266:1991;1672-1677.
41. Schuyler G.T., Yarbrough L.R. Effects of age on myosin and creatine kinase isoforms in left ventricles of fisher 344 rats. Mech. Ageing Dev. 56:1990;23-28.
42. Sugioka K., Nakano M. Mechanism of phospholipid peroxidation induced by ferric ion-ADP-adriamycin-coordination complex. Biochim. Biosphys. Acta. 713:1982;232-236.
43. Timour Q., Nony P., Lang J., Lakhal M., Veronique T., Faucon G. Doxorubicin concentration in plasma and myocardium and their respective roles in cardiotoxicity. Card. Drug Ther. 1:1988;559-560.
44. Thomas C., Carr A.C., Winterbourn C.C. Free radical inactivation of rabbit muscle creatine kinase: catalysis by physiological and hydrolyzed ICRF-187 (ICRF-198) iron chelates. Free Rad. Res. 21:1994;387-397.
45. Thornalley P.J., Dodd N.J. Free radical production from normal and adriamycin-treated rat cardiac sarcosomes. Biochem. Pharmacol. 34:1985;669-674.
46. Thornalley P.J., Bannister W.H., Bannister J.V. Reduction of oxygen by NADH/NADH dehyrogenase in the presence of adriamycin. Free Radic. Res. Commun. 2:1986;163-171.
47. Vatner D.E., Ingwall J.S. Effect of moderate pressure overload cardiac hypertrophy on the distribution of creatine kinase isozymes. Proc. Soc. Exp. Biol. Med. 175:1984;5-9.
48. Vidal R.F., Elksborg S., Sunberg M., Carlberg M., Elfsson B., Anderson B.S. Doxorubicin- and daunorubicin- induced energy deprivation and nucleotide degradation in isolated cardiomyocytes. Toxicology. 114:1996;1-10.
49. Villani F., Monti E., Piccinini F., Favalli L., Lanza E., Rozza A., Poggi P. Relationship between ECG changes and myocardial morphological alterations induced by adriamycin in rat. Tumori. 72:1986;339-344.
50. Weiss R.B., Sarosy G., Clagett-Carr K., Russo M., Leyland-Jones B. Anthracycline analogs: the past, present, and future. Cancer Chemother. Pharmacol. 18:1986;185-197.
51. Yen H.C., Oberley T.D., Vichitbandha S., Ho Y.S., St Clair D.K. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin. Invest. 98:1996;1253-1260.
52. 2 by iron-adriamycin. J. Biol. Chem. 259:1984;6056-6058.